| 000 | 01721 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250514043133.0 | ||
| 264 | 0 | _c20030221 | |
| 008 | 200302s 0 0 eng d | ||
| 022 | _a0172-8172 | ||
| 024 | 7 |
_a10.1007/s00296-002-0217-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRinge, J D | |
| 245 | 0 | 0 |
_aTransdermal fentanyl for the treatment of back pain caused by vertebral osteoporosis. _h[electronic resource] |
| 260 |
_bRheumatology international _cSep 2002 |
||
| 300 |
_a199-203 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Cutaneous |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAnalgesics, Opioid _xadministration & dosage |
| 650 | 0 | 4 |
_aBack Pain _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFentanyl _xadministration & dosage |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOsteoporosis _xcomplications |
| 650 | 0 | 4 | _aPain Measurement |
| 650 | 0 | 4 | _aPatient Satisfaction |
| 650 | 0 | 4 | _aProbability |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 |
_aSpinal Diseases _xcomplications |
| 650 | 0 | 4 | _aStatistics, Nonparametric |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aFaber, H | |
| 700 | 1 | _aBock, O | |
| 700 | 1 | _aValentine, S | |
| 700 | 1 | _aFelsenberg, D | |
| 700 | 1 | _aPfeifer, M | |
| 700 | 1 | _aMinne, H W | |
| 700 | 1 | _aSchwalen, S | |
| 773 | 0 |
_tRheumatology international _gvol. 22 _gno. 5 _gp. 199-203 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00296-002-0217-8 _zAvailable from publisher's website |
| 999 |
_c12096508 _d12096508 |
||